• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过抗体介导的受体聚集诱导 MET 受体酪氨酸激酶下调。

Induction of MET Receptor Tyrosine Kinase Down-regulation through Antibody-mediated Receptor Clustering.

机构信息

School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen, Guangdong, China.

Department of Chemistry and Biochemistry, University of Nevada, Las Vegas, Las Vegas, NV, 89154-4003, USA.

出版信息

Sci Rep. 2019 Feb 13;9(1):1988. doi: 10.1038/s41598-018-36963-3.

DOI:10.1038/s41598-018-36963-3
PMID:30760737
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6374517/
Abstract

The proto-oncoprotein MET is a receptor tyrosine kinase that plays a key role in cancer cell growth and invasion. We have used fluorescence-tagged antibodies to activate MET in live serum-starved glioblastoma cells and monitor the fate of antibody-bound MET receptor in single cell-based assays. We found that the antibodies induced rapid and transient formation of highly polarized MET clusters on the plasma membrane and promoted the activation of MET, resembling the initial effects of binding to its ligand, HGF. However, the antibody-induced clustering and activation of MET led to the rapid removal of the receptor from cell surface and altered its intracellular processing, resulted in rapid degradation of the receptor. Consequently, while cells pre-treated with HGF remain competent to respond to further HGF stimulation, cells pre-treated with antibodies are refractory to further HGF stimulation due to antibody-mediated MET depletion. Removal of MET by sustained treatment of antibodies blocked cancer cell migration and invasion. Our studies reveal a novel mechanism to alter the recycling process of MET in glioblastoma cancer cells by promoting the receptor degradation through a proteasome-sensitive and lysosome-dependent pathway through the ligand-independent activation of MET using anti-MET antibodies.

摘要

原癌蛋白 MET 是一种受体酪氨酸激酶,在癌细胞生长和侵袭中发挥关键作用。我们使用荧光标记的抗体在活的血清饥饿的神经胶质瘤细胞中激活 MET,并在单细胞基础测定中监测抗体结合的 MET 受体的命运。我们发现,抗体诱导质膜上高度极化的 MET 簇的快速和瞬时形成,并促进 MET 的激活,类似于与配体 HGF 结合的初始效应。然而,抗体诱导的 MET 聚类和激活导致受体从细胞表面迅速去除,并改变其细胞内处理,导致受体的快速降解。因此,虽然用 HGF 预处理的细胞仍然能够对进一步的 HGF 刺激作出反应,但由于抗体介导的 MET 耗竭,用抗体预处理的细胞对进一步的 HGF 刺激无反应。通过持续用抗体去除 MET 阻断了癌细胞的迁移和侵袭。我们的研究揭示了一种通过使用抗-MET 抗体通过配体非依赖性激活 MET 来促进通过蛋白酶体敏感和溶酶体依赖性途径的受体降解,从而改变神经胶质瘤癌细胞中 MET 循环过程的新机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400d/6374517/15eed238c604/41598_2018_36963_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400d/6374517/220ddbebe7d8/41598_2018_36963_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400d/6374517/0dc619a3e05e/41598_2018_36963_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400d/6374517/ba80f9e6fa20/41598_2018_36963_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400d/6374517/fb619d041da6/41598_2018_36963_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400d/6374517/92429974b3db/41598_2018_36963_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400d/6374517/37b71a96a4ea/41598_2018_36963_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400d/6374517/8396dbadc4fc/41598_2018_36963_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400d/6374517/47d51810bb2b/41598_2018_36963_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400d/6374517/15eed238c604/41598_2018_36963_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400d/6374517/220ddbebe7d8/41598_2018_36963_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400d/6374517/0dc619a3e05e/41598_2018_36963_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400d/6374517/ba80f9e6fa20/41598_2018_36963_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400d/6374517/fb619d041da6/41598_2018_36963_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400d/6374517/92429974b3db/41598_2018_36963_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400d/6374517/37b71a96a4ea/41598_2018_36963_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400d/6374517/8396dbadc4fc/41598_2018_36963_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400d/6374517/47d51810bb2b/41598_2018_36963_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/400d/6374517/15eed238c604/41598_2018_36963_Fig9_HTML.jpg

相似文献

1
Induction of MET Receptor Tyrosine Kinase Down-regulation through Antibody-mediated Receptor Clustering.通过抗体介导的受体聚集诱导 MET 受体酪氨酸激酶下调。
Sci Rep. 2019 Feb 13;9(1):1988. doi: 10.1038/s41598-018-36963-3.
2
HGF-induced formation of the MET-AXL-ELMO2-DOCK180 complex promotes RAC1 activation, receptor clustering, and cancer cell migration and invasion.HGF 诱导的 MET-AXL-ELMO2-DOCK180 复合物的形成促进了 RAC1 的激活、受体聚集以及癌细胞的迁移和侵袭。
J Biol Chem. 2018 Oct 5;293(40):15397-15418. doi: 10.1074/jbc.RA118.003063. Epub 2018 Aug 14.
3
AXL and MET crosstalk to promote gonadotropin releasing hormone (GnRH) neuronal cell migration and survival.AXL 和 MET 相互作用促进促性腺激素释放激素(GnRH)神经元的迁移和存活。
Mol Cell Endocrinol. 2013 Jul 15;374(1-2):92-100. doi: 10.1016/j.mce.2013.04.018. Epub 2013 May 3.
4
The plasticity of oncogene addiction: implications for targeted therapies directed to receptor tyrosine kinases.癌基因成瘾的可塑性:对靶向受体酪氨酸激酶的靶向治疗的影响。
Neoplasia. 2009 May;11(5):448-58, 2 p following 458. doi: 10.1593/neo.09230.
5
AXL and MET receptor tyrosine kinases are essential for lung cancer metastasis.AXL和MET受体酪氨酸激酶对肺癌转移至关重要。
Oncol Rep. 2017 Apr;37(4):2201-2208. doi: 10.3892/or.2017.5482. Epub 2017 Mar 1.
6
Breast tumor kinase and extracellular signal-regulated kinase 5 mediate Met receptor signaling to cell migration in breast cancer cells.乳腺肿瘤激酶和细胞外信号调节激酶 5 介导了乳腺癌细胞中 Met 受体信号向细胞迁移的作用。
Breast Cancer Res. 2010;12(4):R60. doi: 10.1186/bcr2622. Epub 2010 Aug 5.
7
Interactions between PTEN and the c-Met pathway in glioblastoma and implications for therapy.胶质母细胞瘤中PTEN与c-Met信号通路的相互作用及其治疗意义。
Mol Cancer Ther. 2009 Feb;8(2):376-85. doi: 10.1158/1535-7163.MCT-08-0627. Epub 2009 Feb 3.
8
Fully human monoclonal antibodies to hepatocyte growth factor with therapeutic potential against hepatocyte growth factor/c-Met-dependent human tumors.对肝细胞生长因子具有治疗潜力的全人源单克隆抗体,可对抗依赖肝细胞生长因子/c-Met的人类肿瘤。
Cancer Res. 2006 Feb 1;66(3):1721-9. doi: 10.1158/0008-5472.CAN-05-3329.
9
Direct regulation of GAS6/AXL signaling by HIF promotes renal metastasis through SRC and MET.缺氧诱导因子对GAS6/AXL信号通路的直接调控通过SRC和MET促进肾转移。
Proc Natl Acad Sci U S A. 2014 Sep 16;111(37):13373-8. doi: 10.1073/pnas.1404848111. Epub 2014 Sep 3.
10
MM-131, a bispecific anti-Met/EpCAM mAb, inhibits HGF-dependent and HGF-independent Met signaling through concurrent binding to EpCAM.MM-131,一种双特异性抗-Met/EpCAM mAb,通过同时结合 EpCAM,抑制 HGF 依赖性和非依赖性 Met 信号传导。
Proc Natl Acad Sci U S A. 2019 Apr 9;116(15):7533-7542. doi: 10.1073/pnas.1819085116. Epub 2019 Mar 21.

引用本文的文献

1
Bacterial aggregation facilitates internalin-mediated invasion of .细菌聚集促进内化素介导的……入侵。 (原文此处不完整)
Front Cell Infect Microbiol. 2024 Jul 9;14:1411124. doi: 10.3389/fcimb.2024.1411124. eCollection 2024.
2
Function of hepatocyte spheroids in bioactive microcapsules is enhanced by endogenous and exogenous hepatocyte growth factor.生物活性微胶囊中肝细胞球状体的功能通过内源性和外源性肝细胞生长因子得到增强。
Bioact Mater. 2023 May 24;28:183-195. doi: 10.1016/j.bioactmat.2023.05.009. eCollection 2023 Oct.

本文引用的文献

1
HGF-induced formation of the MET-AXL-ELMO2-DOCK180 complex promotes RAC1 activation, receptor clustering, and cancer cell migration and invasion.HGF 诱导的 MET-AXL-ELMO2-DOCK180 复合物的形成促进了 RAC1 的激活、受体聚集以及癌细胞的迁移和侵袭。
J Biol Chem. 2018 Oct 5;293(40):15397-15418. doi: 10.1074/jbc.RA118.003063. Epub 2018 Aug 14.
2
Results From the Phase III Randomized Trial of Onartuzumab Plus Erlotinib Versus Erlotinib in Previously Treated Stage IIIB or IV Non-Small-Cell Lung Cancer: METLung.METLung:奥沙利umab 联合厄洛替尼对比厄洛替尼治疗既往治疗的 IIIB 或 IV 期非小细胞肺癌的 III 期随机试验结果
J Clin Oncol. 2017 Feb;35(4):412-420. doi: 10.1200/JCO.2016.69.2160. Epub 2016 Dec 12.
3
Acid sphingomyelinase is required for cell surface presentation of Met receptor tyrosine kinase in cancer cells.
酸性鞘磷脂酶是癌细胞中Met受体酪氨酸激酶细胞表面呈递所必需的。
J Cell Sci. 2016 Nov 15;129(22):4238-4251. doi: 10.1242/jcs.191684. Epub 2016 Oct 6.
4
Development of antibody-based c-Met inhibitors for targeted cancer therapy.用于靶向癌症治疗的基于抗体的c-Met抑制剂的研发。
Immunotargets Ther. 2015 Feb 9;4:35-44. doi: 10.2147/ITT.S37409. eCollection 2015.
5
MET is required for the recruitment of anti-tumoural neutrophils.招募抗肿瘤中性粒细胞需要MET。
Nature. 2015 Jun 18;522(7556):349-53. doi: 10.1038/nature14407. Epub 2015 May 18.
6
LY2875358, a neutralizing and internalizing anti-MET bivalent antibody, inhibits HGF-dependent and HGF-independent MET activation and tumor growth.LY2875358 是一种中和内化型抗 MET 二价抗体,可抑制 HGF 依赖性和非依赖性 MET 激活及肿瘤生长。
Clin Cancer Res. 2014 Dec 1;20(23):6059-70. doi: 10.1158/1078-0432.CCR-14-0543. Epub 2014 Sep 17.
7
Met endosomal signalling: in the right place, at the right time.跨内体信号传导:在正确的位置,于正确的时间。
Int J Biochem Cell Biol. 2014 Apr;49:69-74. doi: 10.1016/j.biocel.2014.01.009. Epub 2014 Jan 16.
8
The Met receptor tyrosine kinase: a key player in oncogenesis and drug resistance.Met 受体酪氨酸激酶:致癌和耐药中的关键角色。
Pharmacol Ther. 2014 Jun;142(3):316-38. doi: 10.1016/j.pharmthera.2013.12.014. Epub 2013 Dec 31.
9
A biologist's guide to statistical thinking and analysis.生物学家的统计思维与分析指南。
WormBook. 2013 Jul 9:1-54. doi: 10.1895/wormbook.1.159.1.
10
Monovalent antibody design and mechanism of action of onartuzumab, a MET antagonist with anti-tumor activity as a therapeutic agent.单克隆抗体设计和作用机制的 onartuzumab,一种 MET 拮抗剂具有抗肿瘤活性作为治疗剂。
Proc Natl Acad Sci U S A. 2013 Aug 6;110(32):E2987-96. doi: 10.1073/pnas.1302725110. Epub 2013 Jul 23.